ILC 2019 debrief – Viral Hepatitis

ILC 2019 debrief – Viral Hepatitis

A look back at ILC 2019 – Professor Heiner Wedemeyer talks about Viral Hepatitis

🡻🡻 Key links from the debrief below 🡻🡻

⬢ Watch the lecture on “Ascending dose cohort study of inarigivir – A novel RIG I agonist in chronic HBV patients: Final results of the ACHIEVE trial”:

⬢ Watch the lecture on “Global real world evidence of sofosbuvir/velpatasvir as a simple, effective regimen for the treatment of chronic hepatitis C patients: Integrated analysis of 12 clinical practice cohorts”:

⬢ Watch the lecture on “Efficacy and safety of sofosbuvir monotherapy in patients with chronic hepatitis E – The HepNet SofE pilot study”:

⬢ Download the abstract on “Comparison of tenofovir and entecavir on the risk of hepatocellular carcinoma and liver-related
events in patients with chronic hepatitis B: A propensity score analysis”:

⬢ Watch the lecture on “Short term RNA interference therapy in chronic hepatitis B using JNJ-3989 brings majority of patients to HBsAg (less than 100 IU/mL threshold)”:

⬢ Watch the lecture on “Antigen suppression effect of the core protein allosteric modulator RO7049389 in AAV-HBV mice is accompanied by transient upregulation of immune-cell gene signatures in the liver”:

⬢ Watch the lecture on “What is the most effective approach to a HCV vaccine”:

⬢ Watch the lecture on “Final results of a multicenter, open-label phase 2 clinical trial (MYR203) to assess safety and efficacy of bulevirtide (Myrcludex B) in with PEG-interferon Alpha 2a in patients with chronic HBV/HDV co-infection”:

⬢ Watch the lecture on “End of study results from LIMT HDV study: 36% durable virologic response at 24 weeks post-treatment with pegylated interferon lambda monotherapy in patients with chronic hepatitis delta virus infection”:

⬢ Watch the lecture on “The markers of HBV transcriptional activity – HBcrAg and pre-genomic HBV DNA during antiviral therapy with nucleos(t)ide analogue help to predict optimal timing of therapy withdrawal”:


Xem thêm các bài viết về Sức Khỏe:

Leave a Reply

Your email address will not be published. Required fields are marked *